NexGen Medical Systems

About:

NexGen Medical Systems designs devices that improve the safety of interventional procedures in neurological and cardiovascular patients.

Website: http://nexgenmedsystem.com

Description:

NexGen Medical Systems, Inc. designs medical devices for enhancing the safety of interventional procedures in patients with debilitating neurological and cardiovascular diseases. The company focuses on developing and commercializing thrombectomy medical devices for the removal of blood clots from head, neck, and peripheral vessels. It offers mechanical clot retrieval device, a catheter-based retriever for peripheral arterial and hemodialysis graft indication; an embolic protection device for blood clot removal; PeriCATH, a thrombolytic infusion catheter that enables reliable delivery of thrombolytics to blood clots that extend over long segments of blood vessels without the need for catheter repositioning; and a neurotrauma device for monitoring and treating patients with traumatic head injury, as well as drug and cell delivery devices to deliver therapeutic agents directly to their target receptors. The company was incorporated in 2002 and is based in Reno, Nevada. It also has a research and development, as well as a product development center in Melbourne, Florida. NexGen Medical Systems, Inc. operates as a subsidiary of NexGen Ergonomics Inc.

Total Funding Amount:

$3.55M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Melbourne Beach, Florida, United States

Founded Date:

2002-01-01

Contact Email:

jkucharczyk(AT)nexgenmedsystem.com

Founders:

George T. Gillies, John Kucharczyk, William C. Broaddus

Number of Employees:

1-10

Last Funding Date:

2018-07-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai